Selumetinib safe option for treatment of inoperable plexiform neurofibromas Medical Dialogues Editorial Team7 Jun 2022 6:45 AM GMTSelumetinib is a medication that is both effective and safe for young patients having symptomatic, inoperable plexiform neurofibromas, says an article...
Study demonstrates efficacy of new treatment for neurofibromatosis type 1-related tumors Hina Zahid24 Jan 2021 5:09 PM GMTPhiladelphia: Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers at Children's Hospital of...
FDA approves first treatment for Neurofibromatosis in children Dr. Kamal Kant Kohli11 April 2020 1:38 AM GMTThe U.S. Food and Drug Administration has approved Koselugo (selumetinib) for the treatment of pediatric patients, 2 years of age and older, with...
